Unlocking the full potential of liver cells as medicine
Satellite Bio is a Cambridge, Massachusetts-based biotech company pioneering tissue therapeutics. Its proprietary off-the-shelf liver therapy delivers functional hepatocytes into the body to engraft and restore liver function. The company raised $110M across seed and Series A rounds and emerged from stealth in 2022. It uses drug-like manufacturing for scalable, cost-effective global distribution.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountApr 2022
Feb 2022
Create a free account to see which investors have funded this company.
Create Free Account
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
